(PRWEB) June 14, 2012
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed lawsuits on behalf of three Plaintiffs who suffered from a cerebral hemorrhage after using Plavix and alleges that the defective nature of the drug caused these serious injuries. The suits were filed on May 30th in the Supreme Court of New York, County of New York.
One complaint was filed on behalf of a man from Honolulu, Hawaii who began taking Plavix in October 2009 (Case No. 1068607) and suffered a cerebral hemorrhage in June 2010. Another plaintiff, a woman from Shawnee, Kansas, started Plavix in August 2008 and developed a cerebral hemorrhage in June 2010 (Case No. 1062030). The third lawsuit was filed on behalf of a Louisiana woman who began taking Plavix in 2000 and experienced a cerebral hemorrhage last June (Case No. 2019624). All three lawsuits allege severe and permanent injuries, physical impairment and disfigurement, physical pain and suffering, mental pain and suffering, loss of enjoyment of life and past, present and future medical expenses.
The lawsuits allege that the defendants negligently and/or fraudulently touted Plavix as a safe, effective form of treatment without properly testing the drug for side effects. Due to their alleged actions, the complaints state, users are at a significantly increased risk of heart attack, stroke, internal bleeding, blood disorders and/or death.
Plavix was approved by the U.S. Food and Drug Administration (FDA) in 1997 for the prevention of blood clots, stroke and heart attack in patients who have risk factors for these conditions. By 2005, it was the sixth best-selling drug in the U.S. with annual sales totaling $3.5 billion, according to the complaint. The lawsuit points out that the Defendants marketed Plavix as a “super-aspirin”, claiming that it was more effective than the inexpensive, over-the-counter drug at preventing ischemic events. The suits allege this claim to be false, and state that the manufacturers should have been aware that the risks of Plavix outweigh its benefits.
The complaints state that the Defendants have made a number of false or unsubstantiated claims with regards to Plavix; in particular, the manufacturers had insisted in a promotional letter to physicians that the “dual therapy” of Plavix plus Aspirin was safe. According to the lawsuit, the FDA said in a 2001 warning letter to the Defendants that this claim overstated the benefits of the drug. In 2006, the New England Journal of Medicine published a study analyzing the effects of Plavix compared to a combination therapy of Plavix plus Aspirin in lowering the rate of ischemic events. Based on their findings, researchers concluded that Plavix with Aspirin was not significantly more effective than Aspirin alone in preventing heart attack, stroke or death from cardiovascular causes.
Parker Waichman LLP continues to offer free legal consultations to victims of alleged Plavix side effects, including:
- Cerebral hemorrhage
- Thrombotic Thrombocytopenic Purpura (TTP)
- Gastrointestinal bleeding
- Internal bleeding
- Bone marrow damage
- Heart attack
If you or a loved experienced serious, life-threatening internal bleeding, heart attacks, strokes, or a blood disorder, and you believe Plavix is to blame, please contact their office by visiting the firm's Plavix side effects page at http://www.yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
For more information regarding Plavix side effects lawsuits and Parker Waichman LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney